BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6483 related articles for article (PubMed ID: 17084425)

  • 1. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of small reductions in diastolic blood pressure for primary prevention.
    Cook NR; Cohen J; Hebert PR; Taylor JO; Hennekens CH
    Arch Intern Med; 1995 Apr; 155(7):701-9. PubMed ID: 7695458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
    Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case mix, outcome and activity for patients admitted to intensive care units requiring chronic renal dialysis: a secondary analysis of the ICNARC Case Mix Programme Database.
    Hutchison CA; Crowe AV; Stevens PE; Harrison DA; Lipkin GW
    Crit Care; 2007; 11(2):R50. PubMed ID: 17451605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of first events of coronary heart disease and stroke with consideration of adiposity.
    Wilson PW; Bozeman SR; Burton TM; Hoaglin DC; Ben-Joseph R; Pashos CL
    Circulation; 2008 Jul; 118(2):124-30. PubMed ID: 18591432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global impact of noncommunicable diseases: estimates and projections.
    Manton KG
    World Health Stat Q; 1988; 41(3-4):255-66. PubMed ID: 3232413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Morbidity due to smoking in The Netherlands: an estimated 90,000 clinical hospital admissions in 2005].
    Cruts AA; Feenstra TL; van Laar MW
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1469-72. PubMed ID: 18666665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
    Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
    Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The best of epidemiology and cardiovascular prevention in 2006].
    Thomas D; Collet JP; Cottin Y; Cournot M; Ducimetière P; Ferrières J; Paillard F; Valensi P; Zeller M; Cambou JP
    Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():57-64. PubMed ID: 17405566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 325.